Cellyan Biotechnology (HKPD) Notes Payables (2024 - 2025)

Cellyan Biotechnology (HKPD) posted quarterly Notes Payables of $355466.0 for Q3 2025, down 4.33% quarter-over-quarter from $371558.0 in Q1 2025.

Cellyan Biotechnology (HKPD) Notes Payables (2024 - 2025) Analysis & Trends

Cellyan Biotechnology (HKPD) has reported Notes Payables for 2 consecutive years, with $355466.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Notes Payables changed N/A year-over-year to $355466.0; the TTM figure through Sep 2025 stood at $355466.0 (changed N/A YoY), while the FY2025 annual figure was $371558.0, up 970.65% from the prior year.
Notes Payables slipped to $355466.0 in Q3 2025 per HKPD's latest filing, from $371558.0 in the prior quarter.
Across five years, Notes Payables topped out at $371558.0 in Q1 2025 and bottomed at $34704.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Mckesson	100.02 Bn	94.85 Bn	3.69 Bn
2	Cencora	60.88 Bn	58.06 Bn	3.61 Bn
3	Cardinal Health	54.14 Bn	49.29 Bn	2.56 Bn
4	Henry Schein	10.05 Bn	9.90 Bn	1.10 Bn
5	Akso Health	737.16 Mn	736.96 Mn	-
6	Edap Tms	159.12 Mn	137.58 Mn	7.34 Mn
7	Accendra Health	100.85 Mn	93.20 Mn	263.41 Mn
8	111	32.10 Mn	-26.65 Mn	18.18 Mn
9	Cosmos Health	12.73 Mn	10.29 Mn	1.51 Mn
10	Cellyan Biotechnology	6.55 Mn	6.32 Mn	-

Download Data